1. Home
  2. KOPN vs APLT Comparison

KOPN vs APLT Comparison

Compare KOPN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • APLT
  • Stock Information
  • Founded
  • KOPN 1984
  • APLT 2016
  • Country
  • KOPN United States
  • APLT United States
  • Employees
  • KOPN N/A
  • APLT N/A
  • Industry
  • KOPN Semiconductors
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOPN Technology
  • APLT Health Care
  • Exchange
  • KOPN Nasdaq
  • APLT Nasdaq
  • Market Cap
  • KOPN 282.1M
  • APLT 80.3M
  • IPO Year
  • KOPN 1992
  • APLT 2019
  • Fundamental
  • Price
  • KOPN $1.66
  • APLT $0.65
  • Analyst Decision
  • KOPN Strong Buy
  • APLT Buy
  • Analyst Count
  • KOPN 4
  • APLT 7
  • Target Price
  • KOPN $2.63
  • APLT $6.10
  • AVG Volume (30 Days)
  • KOPN 11.0M
  • APLT 3.5M
  • Earning Date
  • KOPN 03-13-2025
  • APLT 03-05-2025
  • Dividend Yield
  • KOPN N/A
  • APLT N/A
  • EPS Growth
  • KOPN N/A
  • APLT N/A
  • EPS
  • KOPN N/A
  • APLT N/A
  • Revenue
  • KOPN $44,266,305.00
  • APLT N/A
  • Revenue This Year
  • KOPN $21.20
  • APLT N/A
  • Revenue Next Year
  • KOPN $13.55
  • APLT $2,622.90
  • P/E Ratio
  • KOPN N/A
  • APLT N/A
  • Revenue Growth
  • KOPN 0.60
  • APLT N/A
  • 52 Week Low
  • KOPN $0.56
  • APLT $0.54
  • 52 Week High
  • KOPN $2.79
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 51.45
  • APLT 35.67
  • Support Level
  • KOPN $1.58
  • APLT $0.54
  • Resistance Level
  • KOPN $1.94
  • APLT $0.66
  • Average True Range (ATR)
  • KOPN 0.18
  • APLT 0.06
  • MACD
  • KOPN -0.03
  • APLT 0.09
  • Stochastic Oscillator
  • KOPN 29.79
  • APLT 81.26

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: